Revised SPC: Fampyra (fampridine) 10 mg prolonged-release tablets

Contraindication for mild renal impairment (creatinine clearance <50ml/min) has been removed from SPC, vertigo has been added as a common adverse event, and dizziness as a symptom of overdose.

Source:

electronic Medicines compendium